Immunotherapy promise for gynaecologic extra-renal clear cell carcinomas

Nivolumab plus ipilimumab shows clinical benefit as first-line treatment for centrally confirmed MSI-H/dMMR mCRC

Ivonescimab benefit for EGFR mutant NSCLC patients who failed TKI therapy

Monitoring ovarian function in oncology studies

Bortezomib and dexamethasone demonstrate efficacy benefit in key subgroups vs daratumumab, bortezomib, and dexamethasone in RRMM

HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive BC

CAR-T, bispecifics or ADCs in late-stage RRMM

Complementing clinical trials: Investigating the value of real world evidence with insights from TE NDMM

Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI

Treatment of multiple myeloma in Turkey

Melflufen and dexamethasone versus pomalidomide and dexamethasone in relapsed refractory multiple myeloma

Grand Rounds: Improving quality of patient-centred care